# Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

> **NCT07542041** · NA · RECRUITING · sponsor: **ARTIDIS AG** · enrollment: 200 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Neoplasms
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Pancreatic Lesions Located at the Body or the Tail

## Interventions

- **DEVICE:** ARTIDIS ART-1 Device

## Key facts

- **NCT ID:** NCT07542041
- **Lead sponsor:** ARTIDIS AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-05
- **Final completion:** 2030-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07542041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07542041, "Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07542041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*